1. Dahlöf B. Preventing stroke in hypertensive patients at risk: AT-1 receptor blockade as an opportunity. In: Preventing of events in the cardiovascular continuum. Eur Press 2007: 21–6.
2. ASA/AHA. Heart Disease and Stroke Statistics. 2005: 1–60.
3. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack. A statement for healthcare professionals from the stroke council of the American Heart Association. Stroke 1999; 30: 1991–4.
4. ESC Guidelineson the Fourth Joint European Societies Task Force on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2007: 4(Suppl. 2).
5. Lewington S, Clarke R, Qizibash N et al. Age-specific relevance of usual blood pressure to vacular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–13.
6. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association Council on Stroke 2006; 37: 577–617.
7. Antithrombotic Therapy. R.C.Becker, D.J.Fintel, D.Green. 4 Ed. Professional Communications, Inc., 2006.
8. Guidelines for antithrombotic therapy. J Hirsh. 5 Ed. BC Decker Inc., 2005.
9. Скворцова В.И., Стаховская Л.В., Пряникова Н.А. и др. Первичная и вторичная профилактика инсульта. Фарматека 2007; 7: 33–6.
10. ESC Guidelines Desk Reference. Lippincott Williams&Wilkins, 2007.